Supporting Members List of JFMDA Total 138 Companies

Total Page:16

File Type:pdf, Size:1020Kb

Supporting Members List of JFMDA Total 138 Companies Supporting Members List of JFMDA Total 138 Companies 3M JAPAN LIMITED COOK JAPAN ABBOTT JAPAN CO., LTD. COSMOS CORPORATIPON CO., LTD. ABBOTT VASCULAR JAPAN CO., LTD COVIDIEN JAPAN INC. ABIOMED JAPAN K.K. CREATE MEDIC CO., LTD. ACOMA MEDICAL INDUSTRY CO., LTD. DAIICHI SANKYO CO., LTD. ADEKA CORPORATION DAIKEN MEDICAL CO., LTD. ALCON JAPAN, LTD. DENTSPLY SIRONA K.K. AMCO INCORPORATED EDWARDS LIFESCIENCES (JAPAN) LIMITED ANRITSU CORPORATION FAMILY CO., LTD. ASAHI KASEI MEDICAL CO.,LTD FRESENIUS MEDICAL CARE JAPAN K.K. ASAHI ROENTGEN IND. CO., LTD. FUJI FILM MEDICAL CO., LTD. ATOM MEDICAL CORPORATION FUJIFILM CORPORATION B. BRAUN AESCULAP JAPAN CO., LTD. FUKUDA DENSHI CO., LTD. BAXTER LIMITED FUKUDA DENSHI FINETECH SENDAI CO., LTD. BAYER YAKUHIN,LTD. FUKUDA M-E KOGYO CO., LTD. BECKMAN COULTER BIOMEDICAL K.K. FUSO PHARMACEUTICAL INDUSTRIES, LTD. BIOTRONIK JAPAN.INC. GC CORPORATION BOSTON SCIENTIFIC JAPAN K.K. GE HEALTHCARE JAPAN CORPORATION BSI GROUP JAPAN K.K. HAKKO MEDICAL CO., LTD. CARDINAL HELTH JAPAN G.K.. HAMAMATSU PHOTONICS K.K. CM PLUS CORPORATION HITACHI HIGH-TECHNOLOGIES CORPORATION CMIC CO., LTD. HITACHI, LTD. COBRIDGE CO., LTD. HOGY MEDICAL CO., LTD. Name HOYA CORPORATION MEDITRIX CORPORATION HOYA SARVICE CORPORATION MEDTRONIC JAPAN CO., LTD. I.L.JAPAN JAPAN CO., LTD. MEDTRONIC SOFAMOR DANEK, Co., Ltd. IMI CO., LTD. MENICON CO., LTD. INSTITUTE OF IMMUNOLOGY CO., LTD. MICRON CORPORATION J.MORITA MFG. CORP. MIYANO MEDICAL INSTRUMENTS CO., LTD. J.MORITA TOKYO MFG. CORP. MIZUHO CORPOTRATION JAPAN LIFELINE CO., LTD. MSD K.K. JAPAN MEDEICALNEXT CO., LTD. MURANAKA MEDICAL INSTRUMENTS CO., LTD. JAPAN MEDICAL DYNAMIC MARKETING, INC. MUTOH CO., LTD. JAPAN QUALITY ASSURANCE ORGANIZATION NAGASE PLASTICS CO., LTD. JEOL LTD. NAKANISHI INC. JMS CO., LTD. NIHON KOHDEN CORPORATION JOHNSON & JOHNSON K.K. NIHON MEDI-PHYSICS CO., LTD. KANEKA CORPORATION NIHON PALL LTD. KAWASUMI LABORATORIES, INC. NIKKISO CO., LTD. KDK CORPORATION NIPPON BECTON DICKINSON COMPANY, LTD. KONICA MINOLTA JAPAN, INC. NIPPON CONTACT LENS INC. KONISHI MEDICAL & SURGICAL CO., LTD. NIPPON STRYKER K.K. KURARAY NORITAKE DENTAL INC. NIPRO CORPORATION LIBEDO CORPORATION INC. NITTO KOHKI CO., LTD. LUMENIS JAPAN CO., LTD. NTT LOGISCO INC. MARUHO CO., LTD. OLYMPUS CORPORATION MEDICO'S HIRATA INC OMRON HEALTHCARE CO.,LTD. MEDICON, INC. OSADA ELECTRIC CO., LTD. Name OTSUKA PHARMACEUTICAL FACTORY,INC. THE YOSHIDA DENTAL MFG. CO., LTD. PANASONIC CORPORATION TKB CORPORATION PANASONIC HEALTHCARE CO., LTD. TMC CO., LTD. PARAMOUNT BED CO., LTD. TOP CORPORATION PHILIPS ELECTRONICS JAPAN, LTD. MEDICAL TOPCON CORPORATION SYSTEMS PIP TOKYO CO., LTD. TORAY INDUSTRIES, INC. RION CO., LTD. TORAY MEDICAL CO., LTD. SAKURA FINETEK JAPAN CO., LTD. TOSHIBA MEDICAL SYSTEMS CORPORATION SAKURA SEIKI CO., LTD. TOYO MEDIC CO., LTD. SANTEN PHARMACEUTICAL CO., LTD. VOLCANO JAPAN CO.,LTD SEED CO., LTD. VORPAL TECHNOLOGIES K.K. SEIKAGAKU CORPORATION YAGAMI CO., LTD. SENKO MEDICAL INSTRUMENT MFG. CO., LTD. YAMAGUCHI COUNCIL MEDICAL NETWORKING SHIMADZU CORPORATION YAMASHITA MEDICAL INSTRUMENTS CO., LTD. SHOFU INC. YAYOI K.K. SIEMENS HEALTHCARE K.K. YOSHIDA SEIKO MFG, CO., LTD. SMITHS MEDICAL JAPAN LTD. YUFU ITONAGA CO., LTD. SOLASIA PHARMA K.K. SUNFLARE CO.,LTD. SYSMEX CORPORATION TAKARA BELMONT CORPORATION TAKEYAMA CO., LTD. TATSUTA ElECTRIC WIRE & CABLE CO.,LTD. TEIJIN PHAMA LIMITED TERUMO CORPORATION.
Recommended publications
  • Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan
    Haematologica HAEMATOL/2018/194894 Version 3 Haematologica HAEMATOL/2018/194894 Version 3 Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan Naoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, Nobuyuki Aotsuka, Koji Sano, Chikako Ohwada, Jun Kuroki, Hideo Kimura, Michihide Tokuhira, Kinuko Mitani, Kazuhisa Fujikawa, Osamu Iwase, Kohshi Ohishi, Fumihiko Kimura, Tetsuya Fukuda, Sakae Tanosaki, Saori Takahashi, Yoshihiro Kameoka, Hiroyoshi Nishikawa, and Hisashi Wakita Disclosures: 1. This study was supported by research funding from Novartis Pharmaceuticals to N.T. 2. N.T reports grants from Novartis Pharmaceuticals, during the conduct of the study; grants and personal fees from Novartis Pharmaceuticals, grants and personal fees from Otsuka, grants and personal fees from Pfizer, personal fees from Bristol-Myers Squibb, outside the submitted work; K.N reports grants from Zenyaku Kogyo Company, Limited, grants from Chugai Pharmaceutical, grants from Novartis Pharma K.K., grants from Kyowa Hakko Kirin Co, Ltd, grants from Nippon Shinyaku Co, Ltd, outside the submitted work; C.N reports personal fees from Novartis, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Takeda pharmaceuticals, grants and personal fees from Kyowa Hakko Kirin, grants and personal fees from Otsuka Pharmaceutical, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Asahi Kasei Pharma, grants and personal fees from Shionogi, personal fees from Shire, personal fees from Jannsen, personal fees from Celgene, outside the submitted work; M.T. reports personal fees from Bristol-Myers Squib, personal fees from Pfizer, outside the submitted work; K.M reports grants from Kyowa Hakko Kirin Co.
    [Show full text]
  • Final Call for Papers
    Final Call for Papers MOC2021 26th MICROOPTICS CONFERENCE http://moc2021.com/ Sponsored by The Japan Society of Applied Physics (JSAP) Organized by Microoptics Group, JSAP M C Technically co-sponsored by IEEE Photonics Society In cooperation with The Optical Society of Japan IEICE Electronics Society IEEE Photonics Society Japan Chapter IEEE Photonics Society Kansai Chapter The Chemical Society of Japan The Society of Polymer Science, Japan The Laser Society of Japan Optoelectronics Industry and Technology Development Association Japan Optomechatronics Association Japan Photonics Council Hamamatsu City Shizuoka University Sep. 26 (Sun.) - Sep. 29 (Wed.), 2021 Congress Center, ACT CITY Hamamatsu, Shizuoka, Japan May 10 (Mon.) Paper Deadline: April 23 (Fri.), 2021 PLENARY TALKS Dieter Bimberg, CIOMP, CAS / TU Berlin "Novel VCSEL Designs for the Next Generation of Photonic Systems" Federico Capasso, Harvard Univ. "Multifunctional Flat Optics" Tsutomu Hara, Hamamatsu Photonics "Exploring Photonics" Katsumi Kishino, Sophia Univ. "InGaN-Based Nanocolumn Optical Devices" INVITED TALKS Kuo-Ping Chen, National Chiao Tung Univ. "Structural Colors and Lasers by Lattice Resonance in Silicon Nitride Metasurfaces" Simon Fafard, Broadcom Semiconductors ULC "High Efficiency Photovoltaic Power Converters and Application to Optical Power Transmission" Harald Haas, Univ. Strathclyde "Recent Advancements in Optical Wireless Communications" Yuri Kivshar, Australian National Univ. "Metaphotonics and Metasurfaces Governed by Mie Resonances" Jan Meijer, Univ. Leipzig "Quantum Light Sources Using Color Centers in Diamond" Peter O'Brien, Tyndall National Institute "Photonics Packaging for Integrated Photonics, from Research to Pilot-Scale Manufacturing" Wolfgang Osten, Univ. Stuttgart "Optical Metrology and Sensing in Times of Digital Transition" Min Qiu, Westlake Univ. "Microscale Opto-Thermo-Mechanical Actuation in the Adhesive Regime" 2 Niels Quack, Ecole Polytech.
    [Show full text]
  • OCTOBER 2020 PTAB Public Hearing Schedule
    OCTOBER 2020 PTAB Public Hearing Schedule Proceeding No. Serial No. PARTY Date Time 2020-004197 16043641 BIOGEN MA INC Thursday, October 1, 2020 9:00 AM (EDT) ALLERGAN PHARMACEUTICALS 2020-002635 13907447 Thursday, October 1, 2020 9:00 AM (EDT) INTERNATIONAL LIMITED 2020-002276 13612925 BAYER AG (MONSANTO) Thursday, October 1, 2020 9:00 AM (EDT) 2020-002277 13612929 OTSUKA PHARMACEUTICAL CO., 2020-002304 14341306 Thursday, October 1, 2020 9:00 AM (EDT) LTD. 2020-002327 15893354 CELLECTIS Thursday, October 1, 2020 9:00 AM (EDT) 2020-000258 15163285 POLY GROUP LLC Thursday, October 1, 2020 9:00 AM (PDT) 2020-000640 15414456 DISCERNDX INC. Thursday, October 1, 2020 9:00 AM (PDT) 2020-000934 13982470 DENOVO BIOMARKERS INC. Thursday, October 1, 2020 9:00 AM (PDT) THE BOARD OF TRUSTEES OF THE 2020-001247 15175848 LELAND STANFORD JUNIOR Thursday, October 1, 2020 9:00 AM (PDT) UNIVERSITY EDWARDS LIFESCIENCES 2020-001487 14563866 Thursday, October 1, 2020 9:00 AM (PDT) CORPORATION IKEDA FOOD RESEARCH COL LTD 2020-003630 16145178 Thursday, October 1, 2020 1:00 PM (EDT) and PHC CORPORATION 2020-002049 13310632 ADARE PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-000053 13135898 OLEG ILLICH EPSHTEIN Thursday, October 1, 2020 1:00 PM (EDT) 2020-001829 15008646 MERZ PHARMA GMBH & CO. KGAA Thursday, October 1, 2020 1:00 PM (EDT) 2020-002360 15407037 IONIS PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-002113 13729631 L'OREAL Thursday, October 1, 2020 1:00 PM (EDT) 2019-003658 13576565 QUNZHU LI and LI LI Thursday, October 1, 2020 1:00 PM (EDT) 2020-000322 14136660 CYTEC INDUSTRIES INC.
    [Show full text]
  • Sanyo Trading Co., Ltd. Sun Phoenix Mexico SA De CV
    Sanyo Trading Co., Ltd. Sun Phoenix Mexico S.A. de C.V. Company profile 2021/Mar. Corporate Profile Head Office : 2-11, Kanda Nishikicho, Chiyoda-ku, Tokyo Establshed : May 28, 1947(2013/Oct TSE listed: 3176) Capital : US$ 10.0 M Sales(Consolidated) : US$ 832 M(2019/Sep) Employee : 368 (2019/Sep.) Business Groups : Rubber Chemical Machinery & Materials Scientific Instruments Industrial Products Branch : Osaka/Nagoya/Hiroshima office(Japan) Branch : <Americas> New York/Detroit/Irapuato (Mexico) office(Global) <Europe> Dusseldorf <Asia> Shanghai/Tianjin/Guangzhou/Hong Kong/ Bangkok/Ho Chi Minh/Hanoi/Jakarta/Singapore Gurgaon (India) Sun Phoenix Mexico 2. Sun Phoenix Company Profile Comapan : Sun Phoenix México, S.A. de C.V. y N a m e Location : Irapuato, Guanajuato, Mexico President : Yu Kashiki Establish : October, 2013 C a p i t a l : 12 Million Pesos (Sanyo Trading95%, SCOA 5%) Employee : 8 N u m b e r Rubber Business Group -Started import of Synthetic Rubber from Polymer Corporation, Canada in 1952 P r o d u c t : Synthetic Rubber - Rubber: ENR, SBR, RNR, RBR, ECO, ACM, EPDM; etc Rubber Additive - Blowing Agents Oil sealing - Curing agents, Activator, Hose for Automotive Industrial rubber Retardant Agents, Accelerators products materials Engineering plastic - Nylon PA6 / PA66 - PP, ABS, POM, PBT; etc - TPE, TPO Compound - PVC S u p p l i e r : Lanxess (Germany), Rubber Products KaMin (USA), Eiwa Chemical (USA) AF Supercell (Thai) C u s t o m e r : Orotex, Parker Corporation, Molten, Nishikawa Sealing System, Sumitomo Chemical, Mitsui
    [Show full text]
  • CSR Report 2011
    Asahi Kasei Group CSR Report 2011 CSR Report 2011 Asahi Kasei Group Contributing to life and living for people around the world CSR Office 1-105 Kanda Jinbocho, Chiyoda-ku Tokyo 101-8101, Japan Phone: +81-3-3296-3083, Fax: +81-3-3296-3164 www.asahi-kasei.co.jp/asahi/en/csr/ Published September 2011 Purview of report Contents The basis for contributing to life and living for people around Interview with the President the world — our CSR Fundamentals 7 Period under review Operating segments Group Philosophy 9 The primary focus of the report is fiscal 2010 (April 2010 ‒ Pioneering the future with chemistry, Operating segment Consolidated subsidiaries Operating conguration 10 March 2011), and all data shown corresponds to this period contributing to life and living for unless otherwise indicated. Some information pertaining to people around the world The new mid-term management Chemicals Asahi Kasei Chemicals Corp. and 23 others initiative 11 events subsequent to the end of the fiscal has also been included. Overview of operations 13 Homes Asahi Kasei Homes Corp. and 9 others Taketsugu Fujiwara Asahi Kasei products and Organizational scope with Hideki Shirakawa technologies in everyday life 15 The scope of the report is Asahi Kasei Corp. and its Asahi Kasei Pharma Corp., consolidated subsidiaries, except with respect to Responsible Health Care Asahi Kasei Kuraray Medical Co., Ltd., 3 Care, in which case the scope is operations in Japan which Asahi Kasei Medical Co., Ltd., and 11 others implement Asahi Kasei Group’s Responsible Care program. As shown at right, Asahi Kasei has six operating segments Fibers Asahi Kasei Fibers Corp.
    [Show full text]
  • Diversity Management Is the Game Changer
    Diversity Management is the Game Changer J-Win Non-Profit Organization promotes diversity management and helps companies gain a competitive edge Promoting diversity and inclusion is the key - Promote Diversity & Inclusion as a management strategy management strategy for innovation J-Win’s - Help women to build networks and provide opportunities for career Yukako Uchinaga, Board Chair Objectives development We now live in a world of globalization driven by technological advances. Global events are - Contribute building a society where diverse individuals can fully instantaneously interconnected, and this has an influence on the business environment, resulting participate in rapid change. In order for Japanese companies to overcome issues arising in this era of major and sudden global change, they must introduce innovation unbound by traditional values. They must harness the different ways of thinking and diverse values held by the people in their workplaces to establish Women to the TOP! a new business model built upon mutual understanding and respect. The promotion of diversity Developing Female Leaders and inclusion (D&I) is an effective management strategy that will revitalize their organizations, Three layers of Networks and provide an important driving force for innovation. The first step in implementing this type of Executive Network diversity management in Japan is to empower women. Since its establishment in 2007, J-Win has worked to support the advancement of diversity Next Stage Network management within its member companies. We will continue to help our member companies High Potential Network gain a competitive edge, as we cultivate more female leaders capable of succeeding in the global companies of today.
    [Show full text]
  • Brochure Vermed Endotube
    ORDER INFORMATION 4011404C Disposable Tubing - OLYMPUS GI Endoscopes 4011405C Disposable Tubing - PENTAX GI Endoscopes PROVIDING A TAILORED SOLUTION 4011406C Disposable Tubing - FUJIFILM GI Endoscopes 500-600 Series A TAILORED SOLUTION... 4011407C Disposable Tubing - FUJIFILM GI Endoscopes 700 Series for endoscopic irrigation and insuation tubing FUNCTIONALITY – Designed for Optimal Performance 4011409C Disposable Tubing + CO Option - OLYMPUS GI Endoscopes 4011410C Disposable Tubing + CO Option - PENTAX GI Endoscopes 4011411C Disposable Tubing + CO Option - FUJIFILM GI Endoscopes 500-600 Series 4011412C Disposable Tubing + CO Option - FUJIFILM GI Endoscopes 700 Series EFFICIENCY – Enables Efficient Running of the Endoscopic Suite INFECTION CONTROL – Minimises Infection Risk to Improve Patient Outcomes 4011413C CO Insufflation Tubing with Hydrophobic Filter - LUER Connection 4011414C CO Insufflation Tubing with Hydrophobic Filter - ADAPTER Connection 4011415C Connection Adapter for Insufflator OLYMPUS UCR COMPATIBILITY – Comprehensive Range to Simplify Procurement & Stock Management 4011416C Connection Adapter for Insufflator FUJIFILM GW-1 4011417C Connection Adapter for Insufflator FUJIFILM GW-100 The ENDOtube range can cover your lower GI endoscopic irrigation and insuation tubing requirements and meet your needs. 4011418C Disposable Irrigation Tubing - EMED Pump / OLYMPUS GI Endoscopes 4011419C Disposable Irrigation Tubing - OLYMPUS Pump / OLYMPUS GI Endoscopes 4011420C Disposable Irrigation Tubing - ENDOGATOR Pump / OLYMPUS GI Endoscopes LARGE
    [Show full text]
  • OSB Participant List by Research Area
    OSB Participant List by Research Area Contact Centers (CC) • AARP • Air Products and • American Drug Stores Chemicals • AAA • ABB • American Electric Power • Airbus • Accor • Abbott • American Express • Alcatel Lucent • American Electric Power • Abengoa • American International • Alcoa Group • American International • Abu Dhabi National Group Energy Company • Alcon • American Stores Company • Austin Energy • ACC Limited • Alfa • American Water • Bank of America • Access Insurance Holdings • Algonquin Power & • Amgen Utilities • Blue Cross Blue Shield • Accord Holdings • AMIL • ALH Group • Charles Schwab & • ACE • AmInvestment Bank Company • Alitalia • Acea • AMR • Citigroup • ALK Abello • Acer • Amssi • Citizens Gas • Alkermes • Acxiom • Amtran Logistics • Clarke American • Allergan • Adelaide Clinic Holdings • Andrew Corporation • CPS Energy • Alliance & Leicester • Adidas • Anglian Water Services • Direct Energy • Alliance Boots • Advance Food Company • Anritsu • Federal Reserve Bank of • Alliant Techsystems Minneapolis • Advance Publications • Anschutz • Allianz • John Deere • Advanced Coating • Apache • Allied Irish Banks • Technologies Louisville Water Company • Apex Equity Holdings • Advanced Semiconductor • Allstate Insurance • Manila Electric Company Engineering Company • Apple • • • Mellon Financial Adventist Health System Ally Financial • Arcadia Housing • • • MetLife Aegon Alon USA Energy • Arcos Dorados Holdings • • • Morgan Stanley AEON AlpTransit Gotthard • Ardent Health Services • • • NetBank Aera Energy Alstom • Argos •
    [Show full text]
  • Hiroshi Miura
    Hiroshi Miura Bengoshi Asia Pacific Counsel, Skadden Arps Law Office, Tokyo (registered associated office of Skadden Arps Foreign Law Office) Corporate Finance; Mergers and Acquisitions Hiroshi Miura’s practice focuses on corporate finance, general corporate matters, mergers and acquisitions (including transactions involving bank and other regulated companies), and equity finance (including initial public offerings and offerings of preferred securities). Mr. Miura’s experience includes representing Mitsui Sumitomo Insurance Co., Ltd. in its £3.46 billion acquisition of Amlin PLC; Nikkei Inc. in its £844 million acquisition of the Financial Times Group from Pearson PLC; Digital Garage, Inc., in its US$114 million going-private acquisition of its subsidiary econtext Asia Limited (Hong Kong); Marubeni Corporation in its US$2.7 billion (excluding debt) acquisition of Gavilon Group LLC and related preferred equity investment by Japan Bank for International Cooperation; NTT DOCOMO, Inc. in its US$290 million all cash tender offer for Buongiorno S.p.A. (Italy); Advantest Corporation in its US$1.1 billion acquisition of Verigy Ltd. (Singapore); TOMY T: 81.3.3568.2819 Company, Ltd. in its US$860 million acquisition of RC2 Corporation through an all-cash F: 1.917.777.5522 tender offer and related financing; andAioi Insurance Company, Limited in its business [email protected] combination with Nissay Dowa General Insurance Company, Limited and Mitsui Sumitomo Insurance Group Holdings, Inc. to form the largest non-life insurance company group in Japan. Mr. Miura also has represented prominent companies such as Toshiba Corporation, Education Westinghouse Electric UK Limited, CSK Holdings Corporation, DBS Group Holdings Diploma of Completion, the Legal Research and Training Institute of Ltd., Sekisui Chemical Co., Ltd., Hoya Corporation, Sumitomo Mitsui Financial Group the Supreme Court of Japan, 2005 and its subsidiary Sumitomo Mitsui Banking Corporation, TPG Capital, Inc.
    [Show full text]
  • FTSE Japan ESG Low Carbon Select
    2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U.
    [Show full text]
  • Factset-Top Ten-0521.Xlsm
    Pax International Sustainable Economy Fund USD 7/31/2021 Port. Ending Market Value Portfolio Weight ASML Holding NV 34,391,879.94 4.3 Roche Holding Ltd 28,162,840.25 3.5 Novo Nordisk A/S Class B 17,719,993.74 2.2 SAP SE 17,154,858.23 2.1 AstraZeneca PLC 15,759,939.73 2.0 Unilever PLC 13,234,315.16 1.7 Commonwealth Bank of Australia 13,046,820.57 1.6 L'Oreal SA 10,415,009.32 1.3 Schneider Electric SE 10,269,506.68 1.3 GlaxoSmithKline plc 9,942,271.59 1.2 Allianz SE 9,890,811.85 1.2 Hong Kong Exchanges & Clearing Ltd. 9,477,680.83 1.2 Lonza Group AG 9,369,993.95 1.2 RELX PLC 9,269,729.12 1.2 BNP Paribas SA Class A 8,824,299.39 1.1 Takeda Pharmaceutical Co. Ltd. 8,557,780.88 1.1 Air Liquide SA 8,445,618.28 1.1 KDDI Corporation 7,560,223.63 0.9 Recruit Holdings Co., Ltd. 7,424,282.72 0.9 HOYA CORPORATION 7,295,471.27 0.9 ABB Ltd. 7,293,350.84 0.9 BASF SE 7,257,816.71 0.9 Tokyo Electron Ltd. 7,049,583.59 0.9 Munich Reinsurance Company 7,019,776.96 0.9 ASSA ABLOY AB Class B 6,982,707.69 0.9 Vestas Wind Systems A/S 6,965,518.08 0.9 Merck KGaA 6,868,081.50 0.9 Iberdrola SA 6,581,084.07 0.8 Compagnie Generale des Etablissements Michelin SCA 6,555,056.14 0.8 Straumann Holding AG 6,480,282.66 0.8 Atlas Copco AB Class B 6,194,910.19 0.8 Deutsche Boerse AG 6,186,305.10 0.8 UPM-Kymmene Oyj 5,956,283.07 0.7 Deutsche Post AG 5,851,177.11 0.7 Enel SpA 5,808,234.13 0.7 AXA SA 5,790,969.55 0.7 Nintendo Co., Ltd.
    [Show full text]
  • Mass Spectrometer Business Presentation Materials
    Mass Spectrometer Business Presentation Materials Hiroto Itoi, Corporate Officer Deputy General Manager of the Analytical & Measuring Instruments Division Shimadzu Corporation Jul. 3, 2018 Contents I. Introduction • Expansion of Mass Spectrometry ………………………………………………………………… p.3 • History of Shimadzu's Growth in Mass Spectrometry …………………………………………… p.5 II. Overview of Mass Spectrometers • Operating Principle, Demand Trends, and Vendors ……………………………………………… p.9 • Mass Spectra ………………………………………………………………………………………… p.10 • Configuration of Mass Spectrometers …………………………………………………………… p.11 • Ionization …………………………………………………………………………………………… p.12 • Mass Separation …………………………………………………………………………………… p.14 III. Shimadzu's Mass Spectrometer Business • Product Type ………………………………………………………………………………………… p.17 • Application Software ………………………………………………………………………………… p.18 • Growth Strategy for Mass Spectrometer Business ……………………………………………… p.19 • Expand/Improve Product Lines …………………………………………………………………… p.20 • Measures to Expand Application Fields …………………………………………………………… p.24 • Measures to Automate Data Processing Using AI ……………………………………………… p.25 IV. Summary • Future Direction ……………………………………………………………………………………… p.26 July 2018 Mass Spectrometer Business Presentation Materials 2 I. Introduction Expansion of Mass Spectrometry (1) Why Mass Spectrometry? Mass spectrometry is able to analyze a wide variety of compounds with high accuracy and high efficiency (simultaneous multicomponent analysis). It offers superior characteristics that are especially beneficial in the following fields,
    [Show full text]